Acquired hemophilia A in a patient with advanced prostate cancer

Acquired hemophilia A (AHA) is a rare disorder that results from the presence of autoantibodies against the clotting factor VIII (FVIII) causing hemorrhagic disorders. This entity is mostly associated with autoimmune diseases, pregnancy, the postpartum period, drugs and malignancy.

Among the solid cancers, prostate neoplasm is the most common cause of AHA. The management of AHA involves the control of active bleeding and the use of specific therapies to eliminate the inhibitor. The authors describe the case of an 87-year-old man with prostate cancer who developed a bleeding disorder 5 years after the cancer diagnosis. Treatment with prednisone did not reach a satisfactory clinical response, which was only achieved with the association of azathioprine. The patient became asymptomatic with no further bleeding episodes, but developed a fatal sepsis after 3 months of treatment with these immunosuppressive agents.

Autopsy & case reports. 2015 Jun 30*** epublish ***

Daniel da Motta Girardi, Douglas Rafael Almeida Silva, Paula Ribeiro Villaça, Ciro Eduardo Souza, Leonardo Gomes da Fonseca, Diogo Assed Bastos, Paulo Marcelo Gehm Hoff

Clinical Oncology Department - Instituto do Câncer do Estado de São Paulo, São Paulo/SP - Brazil . , Hospital das Clinicas - Faculdade de Medicina - Universidade de São Paulo, São Paulo/SP - Brazil . , Hospital das Clinicas - Faculdade de Medicina - Universidade de São Paulo, São Paulo/SP - Brazil . , Clinical Oncology Department - Instituto do Câncer do Estado de São Paulo, São Paulo/SP - Brazil . , Clinical Oncology Department - Instituto do Câncer do Estado de São Paulo, São Paulo/SP - Brazil . , Clinical Oncology Department - Instituto do Câncer do Estado de São Paulo, São Paulo/SP - Brazil . , Clinical Oncology Department - Instituto do Câncer do Estado de São Paulo, São Paulo/SP - Brazil .

PubMed      Full Text Article

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe